Hao, Dapeng

An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer

An, X., Zhu, Y., Zheng, T., Wang, G., Zhang, M., Li, J., Ji, H., Li, S., Yang, S., Xu, D., et al. (2019) · Molecular Therapy Nucleic Acids

interferon and immune responsesCancer Immunotherapy and Biomarkers

Cited by 188

Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease

Dang, M., Han, G., Lee, H. C., Patel, K. K., Becnel, M. R., Wang, R., Thomas, S. K., Hao, D., Chu, Y., Weber, D. M., et al. (2023) · Cancer Cell

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 55

An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC

Zhang, S., Xu, H., Li, M., Yuan, G., Nie, J., Zhang, Q., Shi, J., Liu, D., Meng, H., Dong, W., et al. (2026) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 27

Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer

Lu, J., Wu, D., Li, C., Zhou, M., & Hao, D. (2014) · Journal of Molecular Medicine

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancer

Cited by 24

Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapy

Sun, J., Bao, S., Xu, D., Zhang, Y., Su, J., Liu, J., Hao, D., & Zhou, M. (2019) · Cell Death & Disease

Ovarian cancer diagnosis and treatmentGene expression and cancer classification

Cited by 23

Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases

Zhao, S., Wang, R., Song, S., Hao, D., Han, G., Song, X., Zhang, J., Pizzi, M. P., Shanbhag, N., Futreal, A., et al. (2023) · iScience

Gastric Cancer Management and OutcomesIntraperitoneal and Appendiceal Malignancies

Cited by 5